SCHEMBL5110143

SCHEMBL5110143

CCOC(=O)c1ccccc1-c1ccccc1B(O)O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.62
HSD17B10 Q99714 4/20 0.54
ALDH1A1 P00352 3/20 0.54
MAPT P10636 2/20 0.50
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
USP2 O75604 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
ALOX15 P16050 1/20 0.50
CYP2C19 P33261 1/20 0.50
MAPK10 P53779 1/20 0.50
PTK2B Q14289 1/20 0.50
NCOA1 Q15788 1/20 0.50
NCOA3 Q9Y6Q9 1/20 0.50
ERN1 O75460 1/20 0.48
CDC25B P30305 2/20 0.47
PDK2 Q15119 1/20 0.46
KDM4E B2RXH2 4/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29710304 0.90 TSHR (0.71) TSHRHSD17B10ALDH1A1MAPTKMT2A
SCHEMBL519974 0.90 TSHR (0.71) TSHRHSD17B10ALDH1A1MAPTKMT2A
SCHEMBL29617021 0.88 TSHR (0.80) TSHRHSD17B10ALDH1A1MAPTKMT2A
SCHEMBL3683272 0.88 TSHR (0.80) TSHRHSD17B10ALDH1A1MAPTKMT2A
SCHEMBL8075091 0.81 TSHR (0.69) TSHRHSD17B10ALDH1A1MAPTKMT2A
SCHEMBL5572323 0.81 TSHR (0.69) TSHRHSD17B10ALDH1A1MAPTKMT2A
SCHEMBL3950053 0.81 TSHR (0.69) TSHRHSD17B10ALDH1A1MAPTKMT2A
SCHEMBL28786302 0.80 TSHR (0.61) TSHRHSD17B10ALDH1A1MAPTKMT2A
SCHEMBL4320539 0.80 TSHR (0.67) TSHRHSD17B10ALDH1A1MAPTKMT2A
SCHEMBL7662054 0.79 TSHR (0.61) TSHRHSD17B10ALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7446222-B2 Phenyl compounds GLAXO GROUP LIMITED (GB) 2008-11-04 US disclosed
US-20060235057-A1 Phenyl compounds GLAXO GROUP LIMITED (GB) 2006-10-19 US disclosed
EP-1556330-A2 PHENYL COMPOUNDS GLAXO GROUP LIMITED (GB) 2005-07-27 EP disclosed
WO-2004039753-A2 PHENYL COMPOUNDS GLAXO GROUP LIMITED (GB) 2004-05-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235057-A1 Phenyl compounds RXRB, CYP2C9, RXFP1 TSHR 213/4885HSD17B10 3180/4885ALDH1A1 1584/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.